Crescent Grove Advisors’s Masco MAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$384K Hold
5,700
– – 0.03% 225
2026
Q2
$464K Hold
5,700
– – 0.04% 192
2026
Q1
$344K Hold
5,700
– – 0.03% 221
2025
Q4
$362K Hold
5,700
– – 0.03% 212
2025
Q3
$401K Sell
5,700
-470
-8% -$33.1K 0.04% 199
2025
Q2
$397K Hold
6,170
– – 0.04% 182
2025
Q1
$429K Sell
6,170
-2,802
-31% -$210K 0.04% 168
2024
Q4
$651K Hold
8,972
– – 0.06% 141
2024
Q3
$753K Buy
8,972
+3,272
+57% +$248K 0.08% 135
2024
Q2
$380K Hold
5,700
– – 0.04% 185
2024
Q1
$450K Hold
5,700
– – 0.05% 194
2023
Q4
$382K Hold
5,700
– – 0.04% 203
2023
Q3
$305K Hold
5,700
– – 0.04% 220
2023
Q2
$327K Buy
5,700
+127
+2% +$6.65K 0.04% 226
2023
Q1
$277K Hold
5,573
– – 0.03% 242
2022
Q4
$260K Hold
5,573
– – 0.03% 238
2022
Q3
$260K Hold
5,573
– – 0.03% 224
2022
Q2
$282K Hold
5,573
– – 0.03% 215
2022
Q1
$284K Hold
5,573
– – 0.03% 239
2021
Q4
$391K Hold
5,573
– – 0.04% 197
2021
Q3
$310K Buy
+5,573
New +$331K 0.03% 199

Other funds holding MAS

Crescent Grove Advisors's MAS Position: Q3 2026 in Review

Crescent Grove Advisors held its Masco (MAS) position steady in Q3 2026 at 5,700 shares worth $384K. The position accounts for 0.03% of the portfolio, ranked #225.

Crescent Grove Advisors first reported a position in MAS in Q3 2021 and has held it in 21 quarters since. The position peaked at $753K in Q3 2024. 197 funds tracked by Wall St. Rank hold MAS as of Q3 2026.

  • Crescent Grove Advisors held 5,700 shares of Masco worth $384K as of Q3 2026.
  • Crescent Grove Advisors left its Masco share count unchanged in Q3 2026.
  • Masco made up 0.03% of Crescent Grove Advisors's portfolio in Q3 2026, its #225 holding.
  • Crescent Grove Advisors first reported a position in Masco in Q3 2021 and has held it in 21 quarters since.
  • Crescent Grove Advisors's Masco position peaked at $753K in Q3 2024.
  • 197 funds tracked by Wall St. Rank held Masco as of Q3 2026.

Based on Crescent Grove Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.